Articles On Creso Pharma (ASX:CPH)

Aussie pot stock Creso Pharma is in a prime position to capitalise on the burgeoning Canadian premium, craft cannabis sector after its subsidiary was granted an amended cannabis 2.0 licence in Canada. The wholly-owned Canadian subsidiary o...

Creso Pharma (CPH) reports a 77 per cent year-on-year (YoY) jump in group revenue to $2.05 million for the September quarterThis result takes Creso’s unaudited year-to-date revenue to roughly $6.4 million, which already exceeds 2021The medi...

Surgeons can now be reimbursed for the use of Orthocell’s nerve-reconstruction device SaaS player ReadyTech is considering a takeover offer from an Aussie private equity firm Creso is raising up to $7.6m to advance sales and marketing of i...

There are reports that regulatory progression on the US cannabis front is getting closer which is good news for ASX-listed Creso Pharma. At a US Senate debate on Sunday Senate Majority Leader Chuck Schumer said Congress is “very close” to...

The ASX has closed lower by 0.9% Elon Musk takes the reins at Twitter and immediately fires everyone in the room Potentia’s making an aggressive play for Nitro Software. Again.   Aussie markets are down for the day, with a dreadful result...

Germany looks to legalise recreational cannabis and US and Canadian companies are paying attention  Neurotech reports success with its cannabis-based drug for paediatric autism symptoms  ECS Botanics has sold its Tasmanian business and a...

Amid a worldwide surge of interest in using psychedelic substances to treat stubborn mental health conditions, the ASX possibly soon could host its first pure-play drug developer in this (mind) expanding field. The private Woke Pharmaceutic...

We take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks from 2021 have gained since listing We also look at the best and worst performing ASX stocks over the past month   There were 191 ASX IPOs in...

Australian medicinal cannabis company Creso Pharma has announced some major changes with the departure of its founder and proposed new branding.

Creso Pharma (CPH) is looking to change its name to Melodiol Global Health to reflect its growth strategyAlso as part of this strategy, Creso welcomes two new directors to its board following the resignation of Non-Executive Director and Fo...

ASX cannabis shares have leapt back onto investor radars and are likely to grab more media headlines in the weeks ahead. While all three are deep in the red today amid wider selling action that sees the All Ordinaries Index (ASX: XAO) down...

ASX pot stocks soared on Friday, with Creso Pharma [ASX:CPH] rising more than 25% after news of a marijuana legislative overhaul in the US flagged by President Biden. The post ASX Pot Stocks Surge on US Cannabis Policy Overhaul appeared fir...

Aussie markets end Friday on a -0.80% disappointment US signals new cannabis laws, good news for Aussie producers Zelensky the hot tip to win a rare mid-war Nobel Peace Prize   The ASX has dribbled  it’s way towards Friday’s -0.80% close,...

ShareCafeASX moves lower amidst fears of another Fed rate hike: Aus shares 0.6% down at noon by Peter Milios   At noon, S&P/ASX 200 is 0.61 per cent or 41.90 points lower at 6775.60, following a tumultuous day in the US markets, as the...

Big news out of the US today with President Joe Biden announcing plans to pardon all federal offenses of cannabis possession in the USA – highlighting the first significant step towards decriminalisation. The announcement also marks initial...

ShareCafeStocks of the Hour: TBN, KGD                    Cannabis stocks were the highlight overnight as President Joe Biden pardoned all prior federal offences of simple marijuana possession. This has flowed through to medicinal cann...

Creso Pharma’s (CPH) Canadian-based psychedelics company Halucenex Life Sciences completes recruitment for its phase two clinical trialThe trial will test the efficacy of psilocybin on people with treatment-resistant Post Traumatic Stress D...

Blood clot programs have taken the spotlight recently as new discoveries made Two ASX health stocks are in the blood clot space Top performing ASX healthcare stocks in the past month Blood clots were top of biotech news this week after re...

Creso Pharma’s (CPH) wholly-owned Canadian subsidiary Mernova Medicinal appoints JMF Growers as maiden distributor of medicinal cannabis products in CanadaUnder the agreement, Mernova will provide JMF Growers with a range of Ritual Green st...

Cambridge says cannabis smokers are not actually lazy, that’s a myth USyd wants to test home-grown cannabis in the ACT Incannex joins the big leagues S&P/ASX300 index   It turns out that the lazy stoner stereotype is actually a myth,...

Popular metaverse gaming platform The Sandbox (SAND) has partnered with the Korean subsidiary of French automotive-industry giant Renault. The Sandbox, which is owned by major crypto-gaming incubator and investor Animoca Brands, confirmed t...

Researchers say data shows transition from illicit to legal use of cannabis Medicinal users are at 37%, compared to 2.5% in 2018 Regulations, quality control and costs still barriers for legal week users   New research from the University...

Creso Pharma’s (CPH) subsidiary, Halucenex Life Sciences, secures an amendment to its Clinical Trial Authorisation (CTA) from Health Canada This marks a key step in commencing a phase two clinical trial testing the efficacy of Halucenex’s...

ASX cannabis shares have been mixed performers on the market in the year to date, but are there better days ahead? Cannabis shares on the ASX include Cronos Australia Ltd (ASX: CAU), Incannex Healthcare Ltd (ASX: IHL), Emyria Ltd (ASX: E...

Creso Pharma’s (CPH) subsidiary, ImpACTIVE, appoints multi-sport performance coach Kolby Tullier as brand ambassador Mr Tullier will be paid US$40,000 (A$56,183) in cash as well as shares over the initial 12 month term of his agreement CPH...

Ice-T is opening a cannabis dispensary in New Jersey this year Snoop Dogg’s venture capital firm led a seed funding round for TSUMo Snacks Incannex ramps up development and manufacturing of IHL-216A drug New Jersey has given Ice-T the gre...

Highlights The ASX 200 benchmark index closed up today (August 8), gaining 0.071% to end at 7,020.60 points. In last five trading sessions, the benchmark index has gained 0.39%, but is down 5.70% on year-to-date basis. Eight out of 11...

Highlights The ASX 200 benchmark index closed up today (August 8), gaining 0.071% to end at 7,020.60 points. In last five trading sessions, the benchmark index has gained 0.39%, but is down 5.70% on year-to-date basis. Eight out of 11...

Creso Pharma’s (CPH) Canadian subsidiary, Mernova medicinal secures new purchase orders in July The company have brought in purchase orders worth C$416,340 (A$465,083) last month, representing growth from its June revenue CPH says the new...

While inflation has gripped the share markets this year, in the real world the most visible manifestation is when motorists drive into a petrol station. For the first time, Australians in 2022 have had to get used to paying in the $2s for...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX Powerplays. Morgans takes conservative app...

Shares in the global energy giant Woodside Energy Group Ltd (ASX: WDS) are down 2% and other ASX energy shares are also having a day in the red. At the time of writing, the Woodside share price is trading at $30.89. It has fallen almost 5...

It’s that exciting time of the year again when many ASX-listed companies spill the tea on their latest financial results. Coincidentally, the reporting season aligns with an inundation of dividends from some of the biggest shares in the S&...

Medicinal cannabis specialist Creso Pharma (CPH) taps private investors for $7 million to support its expansion into the United States CPH will issue 175 million shares at four cents per share, with investors to receive one option for ever...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is fighting hard to stay in positive territory. At the time of writing, the benchmark index is up 4 points to 6,980 points. Four ASX shares that have failed to follow the market high...

Just over a month after the collapse of Health House International’s (ASX: HHI) proposed merger with Zelira Therapeutics (ASX: ZLD), cannabidiol (CBD) innovator Creso Pharma (ASX: CPH) has announced the signing of a non-binding term sheet t...

Mysterious pink glow over Mildura Thailand businesses go nuts for CBD desserts and bubble tea ECS nabs $2m commercial loan facility to invest in new capacity ICYMI a mysterious pink glow above Mildura sent residents into a bit of a frenzy...

ASX 200 is up 0.2% and the XEC is down -0.2% Tension stateside ahead of FOMC decision, EU markets to start flat CPI at 6.1% is better than feared but enough to move the RBA next Tuesday And a crack team of small caps broke out of the ordin...

While the bigger end of the towns tides out pre-earnings blackouts, small caps are making the most of ASX’s green days and fronting investors with cash calls. 

Creso Pharma’s (CPH) targeted acquisition company, Sierra Sage Herbs (SSH), strikes an agreement with FSA Store to produce the group’s plant-based first aid collection The companies have executed a non-exclusive private label manufacturing...

The deal between Creso’s acquisition target Sierra Sage Herbs could potentially open up a huge opportunity for new markets. Creso Pharma (ASX:CPH)’s target acquisition company, Sierra Sage Herbs (SSH), has secured a private label agreement...

Creso Pharma’s (CPH) Canadian subsidiary, Mernova Medicinal, generates new purchase orders through the Ontario Cannabis Store’s (OCS) retail flow-through program The OCS program expands the company’s distribution reach, with easier access...

US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F...

Creso Pharma (CPH) progresses activities for its phase two clinical trials, to test the effectiveness of psilocybin in treating post-traumatic stress disorder (PTSD) The company applied to include additional cohorts in the study, which wil...

ECS is selling its medicinal cannabis farm in Tasmania Crypto ATMs are now a thing in weed dispensaries in the US Zelira Therapeutics nabs regulatory approval in Germany for insomnia medication Ever fancied your own cannabis farm? Well, t...

Creso Pharma (CPH) subsidiary Creso ImpACTIVE appoints three new brand ambassadors to drive awareness and potential sales of its CBD medicinal products The three ambassadors include professional golfers Kelly Whaley and Will Wilcox as well...

Creso Pharma (CPH) executes a letter of intent (LOI) with Providence Animal Health Korea to bring its anibidiol product suite to the South Korean market The partnership will work towards the registration, importation and commercialisation...

Creso Pharma (CPH) signs a heads of agreement with leading pet care distributor Gotro Global to introduce its subsidiary Sierra Sage Herbs’ pet care products to Singapore Under the agreement, Gotro will market select products of Sierra’s r...

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

Retail and independent cannabis lounges could be opening soon in Vegas Cann Group gets good manufacturing practice (GMP) licence for its Mildura facility Bod plans to launch a low dose CBD schedule 3 product into the Australian market  ...